Thomas Hope
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Thomas Hope sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Thomas Hope: 13 sponsored US clinical trials, 5 recruiting.
Thomas Hope sponsors 13 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. 3 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Very High Risk Prostate Carcinoma, with 1 trials.
Top-decile sponsor footprint
Thomas Hope ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
13 total, page 1 of 1
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
NCT06961084
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
NCT07054346
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
NCT06474533
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
NCT04895631
Imaging of Solid Tumors Using FAP-2286
NCT04621435
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
NCT04716725
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
NCT05180162
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
NCT04044937
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
NCT03803475
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
NCT03353740
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
NCT03197012
18F-Fluorocholine for the Detection of Parathyroid Adenomas
NCT03764007
Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients
NCT02611882
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Therapeutic Areas
What is open in the Thomas Hope pipeline
5 recruiting of 13 indexed (38% open); 7 completed (54%).
Phase mix: 3 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Very High Risk Prostate Carcinoma (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Thomas Hope: open-pipeline peers nationwide
Peers matched on 13 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Thomas Hope sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 38% open enrollment (± trial volume)
- Morehouse School of Medicine · 38% recruiting · 13 trials
- Northeastern University · 38% recruiting · 39 trials
- William Stoops · 38% recruiting · 13 trials
- Xenon Pharmaceuticals · 38% recruiting · 13 trials
Related
What to do with this Thomas Hope page
13 registered trials is a research-attention snapshot, not an endorsement of Thomas Hope or any single study.
- 5 of Thomas Hope's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Very High Risk Prostate Carcinoma is the condition Thomas Hope studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Very High Risk Prostate Carcinoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Thomas Hope pipeline card: 13 registered trials from official public datasets.Report a data error.